Sensus Healthcare, Inc.

DB:5TX Stock Report

Market Cap: €113.5m

Sensus Healthcare Valuation

Is 5TX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 5TX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 5TX (€6.95) is trading below our estimate of fair value (€15.42)

Significantly Below Fair Value: 5TX is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 5TX?

Key metric: As 5TX is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 5TX. This is calculated by dividing 5TX's market cap by their current earnings.
What is 5TX's PE Ratio?
PE Ratio18.8x
EarningsUS$6.65m
Market CapUS$119.48m

Price to Earnings Ratio vs Peers

How does 5TX's PE Ratio compare to its peers?

The above table shows the PE ratio for 5TX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average22.6x
PUS PULSION Medical Systems
26.7xn/a€134.4m
SBS Stratec
35.3x25.4%€353.7m
EUZ Eckert & Ziegler
21.3x4.0%€802.1m
DRW3 Drägerwerk KGaA
7.2x2.0%€792.8m
5TX Sensus Healthcare
18.8x24.2%€119.5m

Price-To-Earnings vs Peers: 5TX is good value based on its Price-To-Earnings Ratio (18.8x) compared to the peer average (22.6x).

Price to Earnings Ratio vs Industry

How does 5TX's PE Ratio compare vs other companies in the European Medical Equipment Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
5TX 18.8xIndustry Avg. 29.9xNo. of Companies8PE01632486480+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 5TX is good value based on its Price-To-Earnings Ratio (18.8x) compared to the European Medical Equipment industry average (29.9x).

Price to Earnings Ratio vs Fair Ratio

What is 5TX's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

5TX PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio18.8x
Fair PE Ratio26.9x

Price-To-Earnings vs Fair Ratio: 5TX is good value based on its Price-To-Earnings Ratio (18.8x) compared to the estimated Fair Price-To-Earnings Ratio (26.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 5TX forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€6.95
€10.45
+50.3%
15.7%€13.30€9.50n/a4
Nov ’25€5.85
€9.57
+63.5%
8.2%€10.93€9.11n/a4
Oct ’25€5.10
€9.77
+91.6%
8.8%€10.99€9.16n/a3
Sep ’25€5.75
€9.77
+69.9%
8.8%€10.99€9.16n/a3
May ’25€3.12
€6.92
+121.9%
6.7%€7.38€6.46n/a2
Apr ’25€3.54
€6.46
+82.5%
11.7%€7.39€5.54n/a3
Mar ’25€3.74
€6.61
+76.7%
10.4%€7.42€5.56n/a4
Feb ’25€2.96
€5.53
+87.1%
26.4%€7.38€3.69n/a4
Jan ’25€2.14
€5.03
+134.6%
27.3%€7.32€3.66n/a4
Dec ’24€2.18
€5.05
+132.3%
25.1%€7.49€3.74n/a5
Nov ’24€2.03
€6.93
+240.9%
6.4%€7.30€6.39€5.855
Oct ’24€2.46
€6.93
+182.1%
6.4%€7.30€6.39€5.105
Sep ’24€2.82
€6.93
+146.1%
6.4%€7.30€6.39€5.755
Aug ’24€2.69
€7.44
+177.0%
11.9%€9.08€6.36€5.805
Jul ’24€2.96
€7.44
+151.7%
11.9%€9.08€6.36€4.885
Jun ’24€2.47
€7.44
+201.2%
11.9%€9.08€6.36€5.155
May ’24€4.22
€13.87
+228.7%
20.4%€18.62€10.24€3.125
Apr ’24€4.64
€13.87
+199.0%
20.4%€18.62€10.24€3.545
Mar ’24€6.40
€13.87
+116.7%
20.4%€18.62€10.24€3.745
Feb ’24€8.30
€14.27
+71.9%
19.6%€18.53€10.19€2.965
Jan ’24€6.95
€15.36
+121.0%
20.2%€20.07€11.04€2.145
Dec ’23€6.35
€15.36
+141.8%
20.2%€20.07€11.04€2.185
Nov ’23€14.20
€16.73
+17.8%
12.7%€20.28€14.19€2.035

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

Ship Healthcare Holdings

JP¥194.6b

Engages in the medical, healthcare, welfare, and nursing care businesses worldwide.

5EZ

JP¥12.30

7D

-9.6%

1Y

-4.7%

CVS Health

US$68.3b

Provides health solutions in the United States.

CVS

US$52.20

7D

-2.4%

1Y

-16.6%

Shandong Weigao Group Medical Polymer

HK$20.4b

Engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China.

UK2

HK$0.53

7D

-9.5%

1Y

-41.3%